China BCT Pharmacy Group, Inc.
CNBI · OTC
12/31/2012 | 12/31/2011 | 12/31/2010 | 12/31/2009 | |
|---|---|---|---|---|
| Revenue | $242 | $257 | $201 | $136 |
| % Growth | -6.1% | 28.2% | 47.6% | – |
| Cost of Goods Sold | $193 | $196 | $152 | $101 |
| Gross Profit | $49 | $62 | $49 | $36 |
| % Margin | 20.1% | 24% | 24.3% | 26.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $12 | $12 | $8 | $5 |
| SG&A Expenses | $19 | $20 | $13 | $8 |
| Sales & Mktg Exp. | $8 | $7 | $5 | $4 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $19 | $20 | $13 | $9 |
| Operating Income | $29 | $42 | $35 | $27 |
| % Margin | 12.2% | 16.4% | 17.6% | 19.8% |
| Other Income/Exp. Net | -$1 | $0 | -$1 | -$1 |
| Pre-Tax Income | $29 | $42 | $35 | $26 |
| Tax Expense | $7 | $11 | $9 | $6 |
| Net Income | $21 | $31 | $26 | $19 |
| % Margin | 8.7% | 12.1% | 12.8% | 14.3% |
| EPS | 0.42 | 0.72 | 0.67 | 0.61 |
| % Growth | -41.7% | 7.5% | 9.8% | – |
| EPS Diluted | 0.42 | 0.72 | 0.67 | 0.61 |
| Weighted Avg Shares Out | 38 | 38 | 38 | 32 |
| Weighted Avg Shares Out Dil | 38 | 38 | 38 | 32 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $2 | $1 | $1 | $1 |
| EBITDA | $32 | $45 | $37 | $28 |
| % Margin | 13% | 17.3% | 18.3% | 20.7% |